ConductScience.org, home

Paper3500513

Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

Velu TJ and 6 others. Science, 1987. Cited by 454 papers, by iCite.

Cite this record

ConductScience Library. Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. Papers, record 3500513. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3500513

Download JSON
Cell line
EGFR-T172 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.
PubMed
Journal
Science
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
454
iCite
Relative citation ratio, by iCite
9.32
iCite
Revised in PubMed
2021-12-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Velu TJT J
2Beguinot LL
3Vass WCW C
4Willingham MCM C
5Merlino GTG T
6Pastan II
7Lowy DRD R

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell Transformation, NeoplasticMajor topic
Epidermal Growth FactorMajor topic
ErbB ReceptorsMajor topic
Proto-OncogenesMajor topic
Animals
Cells, Cultured
DNA, Recombinant
Fibroblasts
Genetic Vectors
Harvey murine sarcoma virus
Humans
Male
Mice
Mice, Nude
Neoplasms, Experimental
Proto-Oncogene Mas
Recombinant Proteins

Source PubMed

Download CSV of topics

Cited by137

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 454 citations.

PMIDTitleJournalYearIn PapersSource
38201528Progress in Glioma Stem Cell Research.Cancers (Basel)2023https://conductscience.org/library/papers/38201528PubMed
38073064SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma.Mol Oncol2024https://conductscience.org/library/papers/38073064PubMed
37768281Building a large gene expression-cancer knowledge base with limited human annotations.Database (Oxford)2023https://conductscience.org/library/papers/37768281PubMed
37446288An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma.Int J Mol Sci2023https://conductscience.org/library/papers/37446288PubMed
37425733SOS2 regulates the threshold of mutant EGFR-dependent oncogenesis.bioRxiv2023https://conductscience.org/library/papers/37425733PubMed
36125064EGFR, the Lazarus target for precision oncology in glioblastoma.Neuro Oncol2022https://conductscience.org/library/papers/36125064PubMed
35864539The mitochondrial unfolded protein response (UPRmt): shielding against toxicity to mitochondria in cancer.J Hematol Oncol2022https://conductscience.org/library/papers/35864539PubMed
35565451Muscarinic Receptors Associated with Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/35565451PubMed
31508364Rethink of EGFR in Cancer With Its Kinase Independent Function on Board.Front Oncol2019https://conductscience.org/library/papers/31508364PubMed
31430896EGFR-c-Src-Mediated HDAC3 Phosphorylation Exacerbates Invasion of Breast Cancer Cells.Cells2019https://conductscience.org/library/papers/31430896PubMed
30241301Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer.Cancers (Basel)2018https://conductscience.org/library/papers/30241301PubMed
29662194An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo.Oncogene2018https://conductscience.org/library/papers/29662194PubMed
28874603Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins.Sci Signal2017https://conductscience.org/library/papers/28874603PubMed
28513565Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways.Cancers (Basel)2017https://conductscience.org/library/papers/28513565PubMed
26646697Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer.Oncotarget2016https://conductscience.org/library/papers/26646697PubMed
26630010Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26630010PubMed
26182292P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway.PLoS One2015https://conductscience.org/library/papers/26182292PubMed
26004186The CREB Coactivator CRTC2 Is a Lymphoma Tumor Suppressor that Preserves Genome Integrity through Transcription of DNA Mismatch Repair Genes.Cell Rep2015https://conductscience.org/library/papers/26004186PubMed
25506469Molecular detection, phylogenetic analysis, and identification of transcription motifs in feline leukemia virus from naturally infected cats in malaysia.Vet Med Int2014https://conductscience.org/library/papers/25506469PubMed
25503978Constitutive and ligand-induced EGFR signalling triggers distinct and mutually exclusive downstream signalling networks.Nat Commun2014https://conductscience.org/library/papers/25503978PubMed

See all 137 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3500513

GET https://conductscience.org/api/papers/v1/3500513/cited_by?page=2